Related Experiment Video
Updated: May 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Dabigatran overdose secondary to acute kidney injury and amiodarone use
Christos Fountzilas1, Jerry George, Randy Levine
1Department of Medicine, Lenox Hill Hospital, 100 E 77 St, 10075, New York, NY, USA. cfountzilas@nshs.edu
Oral direct thrombin inhibitors have improved treatment of non-valvular atrial fibrillation. Safety concerns have been raised since there is no antidote for treatment of secondary haemorrhages and the absence of widely validated test to monitor drug levels. We present a case of dabigatran overdose in an 82-year-old female who was treated with a seemingly appropriate dose.
Oral direct thrombin inhibitors have improved treatment of non-valvular atrial fibrillation. Safety concerns have been raised since there is no antidote for treatment of secondary haemorrhages and the absence of widely validated test to monitor drug levels. We present a case of dabigatran overdose in an 82-year-old female who was treated with a seemingly appropriate dose.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Acute Kidney Injury II: Pathophysiology
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Cardiac Catheterization I: Pre-Procedure Overview

